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MOLECULAR BIOLOGY/RECEPTORS/HORMONES
Mutation Prognosis No. of Families
Arg719 Trp malignant 4 (3.3% of total)
Arg403Gln malignant 3 (2.5% of totall
Arg453CYs malignant 3 (2.5% of total)
Leu908Vai benign 2(1.6% of total)
Val606 Met benign 1 (0.8% of total)
GI/41 Arg benign 1(0.8% of total)
ISO PSP (mmHg) dP/dtmin (mmHg/s) Tau (msec)
C TG C TG C TG
basal 70 ± 3 70 ± 3 -3042 ± 196 -4766 ± 356 13.6 ± 15 8.2 ± 05
p' ns <0.001 <0.005
0.01 ng gO ± 5 85 ± 5 -4233 ± 226 -6258 ± 628 13.4 ± 1.1 9.3 ± 07
p' ns <0.01 <0.01
1 ng 97 ± 5 79 ± 3 -5223 ± 655 -5434 ± 474 12.5 ± 1.4 99 ± 0.05
p' <001 os ns
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PSP = LV peak systolic pressure, Tau calculated using a mono-exponential model with
zero asymptote.• ANOVA C YS. TG
In conclusion, overexpression of ,8rADR resulted in a significant reduc-
tion in LV dP/dtmin associated with a shortening of Tau which was largely
unaffected by ISO infusion. This suggests markedly enhanced myocardial
relaxation in vivo which is most likely due to increased Ca2+ uptake into the
sarcoplasmic reticulum.
We have previously shown that the inotropic state of the intact mouse can
be significantly increased with overexpression of the ,82-adrenergic recep-
tor (,8rADR). However whether processes involving myocardial relaxation
would also be influenced are unknown. Accordingly, transgenic mice that
were created with cardiac-specific overexpression of the ,82-ADR (~200 fold
increase in ,8-ADR density and ~2 fold increase in basal adenylyl cyclase ac-
tivity) were studied using a 2F high fidelity micromanometer placed in the
left ventricle (LV) of anesthetized intact transgenic (TG) (n = 7) and control
(CI (n = 7) mice. Hemodynamic parameters measured were LV pressure,
minimum first derivative of the LV pressure (LV dP/dtmin) and the time con-
stant of isovolumic LV pressure decay(Tau) at baseline and after progressive
doses of isoproterenol (ISO).
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tein measurements in black bears have not been reported. This study in-
vestigates the concentrations of CHOL and lipoproteins in denning and
non-denning black bears. Serum CHOL concentrations were measured in
1052 serum samples drawn from wild black bears in both the denning and
non-denning states. Non-denning bears were immobilized with ketamine (5
mg/kg) and xylazine (2 mg/kg) whereas denning bears were immobilized with
ketamine (12 mglkg) or tiletamine and zolezapam (4.5 mglkg). Serum total
lipids (TLlP), CHOL and lipoproteins were measured in ten denning bears (4
males, 3 females and 3 lactating females with cubs). CHOL and lipoproteins
also were measured in a non-denning female. Denning bears were fasting
whereas non-denning bears were trapped with high fat content foods and
were non-fasting. Non-denning bears had significantly lower CHOL levels
than denning bears. CHOL levels in denning bears were higher in early winter
(Nov/Dec) than late winter (Feb/Mar). Males had higher CHOL levels than fe-
males during winter, but not during summer. Yearlings had lower CHOL levels
than adults in winter. In the subpopulation of ten denning bears, TliP were
1247 ± 454 mg/dl (range 639-2167); triglycerides (TRIG) were 351 ± 180
mg/dl (range 111-680); CHOL were 376 ± 162 mg/dl (range 175-695); HDL
were 111 ± 35 mg/dl (range 82-185); LDL were 129 ± 66 mg/dllrange 47-
228); and VLDL were 53 ± 22 mg/dl (range 22-87). HDL. LDL and VLDL levels
were not ascertained in three bears because the precipitation technique was
not possible and triglycerides were too high. The CHOL/HDL ratio was 2.8 ±
1.1 (range 1.7-4.8). Values at the lower range for TLiP. TRIG, CHOL, LDL and
VLDL in this subgroup were found in two of the lactating females, who also
had high HDL concentrations. Values for the non-denning female were TRIG
318, CHOL 298, HDL 210, LDL 24, VLDL 64 and CHOL/H DL 1.4. This bear
recently had consumed 10 kgs of bacon. Conclusions: This study confirms
previous reports that CHOL levels are high in black bears, especially during
denning. Further, it demonstrates that, although CHOL, LDL and VLDL con-
centrations were in the range associated with development of human AHD,
the HDL levels were much higher than observed in most human studies. In
fact, the CHOL/HDL ratio was low to low-normal in all bears, including the
bear which had consumed a high fat meal. These data imply that a high HDL
concentration, along with a low CHOllHDL ratio, confers protection against
development of AHD in black bears despite high serum lipid concentrations.
Further investigation could yield information of therapeutic benefit for man.
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Hypertrophic cardiomyopathy (HCM), an autosomal dominant disease and
the most common cause of sudden death in the young, is diagnosed by
echocardiographic detection of cardiac hypertrophy. Unfortunately, the hy-
pertrophy is usually not detectable until adolescence, which may be too late
since sudden death often occurs as the first symptom. The availability of a
clinical genetic assay to detect mutations would provide a definitive diag-
nosis, independent of clinical features and can be made at or before birth.
Computer analysis showed most of the known mutations in the ,8MHC gene
involve a restriction enzyme recognition site which can be exploited as a
rapid genetic screening test. Accordingly, we employed polymerase chain
reaction (PCR) to amplify the involved region of the gene followed by en-
zyme restriction digestion for 15 known mutations in 122 families with HCM.
Fourteen families were positive and 108 negative. Ten families carried one
of the three mutations known to have a high incidence of sudden death with
26 offspring having the mutation and at risk for sudden death while 49 did
not have the mutation and are not at risk of developing HCM. Four families
had one of the three known benign mutations with 23 offspring having the
mutation and 21 without. The mutations were confirmed by sequencing and
shown to be co-inherited with the disease. This test provides for a definitive
genetic diagnosis and identifies those with the mutation and at risk for HCM
and those without who will not develop HCM. Genetic counseling can be
given prior to development of symptoms and those with mutations having
a high incidence of sudden death are candidates for electrophysiology test-
ing and possible implantation of cardiac defibrillators or amiodarone therapy.
The test requires only a blood sample, is simple to perform and results are
available in 48 hours. Over 25 of the ,8MHC mutations have now been shown
to be amenable to rapid genetic diagnosis using PCR and restriction enzyme
digestion.
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We have previously documented that transfection of antisense ODN by a
highly efficient Sendai virus (HVJ)-liposome delivery system can be utilized
to modify lesion formation within the peripheral vasculature in vivo. In this
study, we defined the feasibility of modifying cardiac cell gene expression
via a catheter-based coronary infusion of AS ODN in rabbits. The coronary
artery was cannulated via an over-the-wire approach from the carotid artery.
Fluorescein IF)-Iabeled ODN were utilized to evaluate the cellular distribution
and kinetics of ODN uptake within the myocardium after a single intralumi-
nal bolus of HVJ-liposomes containing ODN. Cellular uptake of F-ODN was
primarily localized in the microvasculature and significant staining was also
observed in conduit vessels and cardiac myocytes. Immunohistochemical
analysis verified prominent localization of F-ODN within the microvascular
endothelium. Expression of F-ODN was observed within 10 minutes, peaked
at 1 day, and remained evident for up to one week after transfection by the
HVJ-liposome method. In contrast. F-ODN infused within liposomes without
the viral particle exhibited transient expression that was undetectable within
3 days. These findings indicate that a single intracoronary bolus infusion of
ODN within HVJ-liposomes is a reproducible methodology for delivery of AS
ODN to targeted cells within the myocardium. Future studies will charac-
terize the feasibility of using this approach to modify cardiac structure and
function via regulating myocardial cell gene expression.
